Rosemont Pharmaceuticals Ltd. (Acquired By Bio-Technology General Corp.)
Yorkdale Industrial Park; Rosemont House
Braithwaite Street
Leeds
LS11 9XE
United Kingdom
Tel: 44-113-2441400
Fax: 44-113-2460738
7 articles about Rosemont Pharmaceuticals Ltd. (Acquired By Bio-Technology General Corp.)
-
Juno Pharmaceuticals Partners With Rosemont Pharmaceuticals as Exclusive Canadian Distributor to Offer Previously Inaccessible Medicines
4/25/2023
Juno Pharmaceuticals Canada announced its partnership with U.K. based developer, manufacturer and global supplier of novel, Rx, oral liquid medicines, Rosemont Pharmaceuticals (“Rosemont”), as its exclusive Canadian distributor.
-
Perrigo Furthers Its Consumer-Focused Transformation By Divesting Its U.K. Generic Prescription Pharmaceuticals Business For £156 Million Or Approximately $195 Million
6/19/2020
Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has reached a definitive agreement to sell its U.K.-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to a U.K.-headquartered private equity firm for £156 million or approximately $195 million in cash. This
-
TLC Therapeutics Announces Multi-Product Licensing And Manufacturing Agreement With Rosemont Pharmaceuticals Ltd.
1/6/2017
-
Perrigo Company Buys Rosemont Pharmaceuticals Ltd. for $283 Million
2/11/2013
-
Rosemont Pharmaceuticals Ltd. Put Up for Sale With £200 Million Price Tag
9/25/2012
-
Savient Pharmaceuticals, Inc. Completes Sale Of Rosemont Pharmaceuticals Ltd. Subsidiary For $176 Million
8/4/2006
-
Savient Pharmaceuticals, Inc. Announces Exploration Of Strategic Alternatives For Rosemont Pharmaceuticals Ltd. Subsidiary Including Potential Spin Out Or Sale Of Business
2/17/2006